BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Direct Healthcare Professional Communication (DHPC) on Minprostin®, Prepidil®, Propess® (dinoprostone-containing drugs): updates to product information on risk reduction of uterine hyperstimulation, uterine rupture, and fetal/neonatal death.

Active substance: dinoprostone

The product information for dinoprostone-containing drugs (Minprostin®, Prepidil®, Propess®) is updated.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 295KB, File is accessible